ClinicalTrials.Veeva

Menu

Nasr Fascial Closure: A Novel Device for Fascial Closure in Laparoscopic Surgery

C

ClinAmygate

Status

Enrolling

Conditions

Cholecystolithiasis

Treatments

Device: Berci Fascial Closure Device
Device: Nasr fascial closure device

Study type

Interventional

Funder types

Other

Identifiers

NCT06036303
PR00C1945

Details and patient eligibility

About

The study will investigate the efficacy and safety of a new fascial closure device "Nasr Fascial Closure Device" compared to the Karl Storz Berci Fascial Closure Device 26173AM.

Enrollment

160 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age > 18
  • eligible for Laparoscopic cholecystectomy

Exclusion criteria

  • refused to participate

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

160 participants in 2 patient groups

Nasr Fascial Closure Device
Experimental group
Treatment:
Device: Nasr fascial closure device
Berci Fascial Closure Device
Active Comparator group
Treatment:
Device: Berci Fascial Closure Device

Trial contacts and locations

1

Loading...

Central trial contact

Emad R Issak, MSc; Mohie El-Din M Madany, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems